Touchdown Neurotech

Touchdown Neurotech is dedicated to transforming the neuromodulation market access landscape for North American companies seeking to expand into Europe. With a wealth of knowledge accumulated over 25 years, Touchdown Neurotech possesses the expertise needed to convert innovative healthcare and wellness products into thriving commercial ventures.

Focusing on serving select North American neurotechnology and neuromodulation companies, Touchdown Neurotech is committed to introducing and establishing their commercial presence in the UK, Europe, and other key international territories. The primary address for Touchdown Neurotech is in London, GB. Touchdown Neurotech takes actionable responsibility for ensuring the success of your product outside of the United States, delivering tangible results and fostering sustainable growth.

Touchdown Neurotech offers immediate access to a network of neurotech professionals, effectively extending your core team and facilitating rapid expansion into new and vital markets. Touchdown Neurotech understands the complexities of commercializing medical technologies and is poised to guide and execute strategies that mitigate risks and ensure commercial success. We invite the company’s management to create a customized and exclusive company showcase and product listing on our platform.